2024
104. Polycystic Ovary Syndrome and Mental Health Co-Morbidities in Adolescents
ONeill N, Lynn A, Zamani M, Kuehne A, Miclette K, Rowe E, Fussner L, Vash-Margita A. 104. Polycystic Ovary Syndrome and Mental Health Co-Morbidities in Adolescents. Journal Of Pediatric And Adolescent Gynecology 2024, 37: 288-289. DOI: 10.1016/j.jpag.2024.01.111.Peer-Reviewed Original ResearchPolycystic ovary syndromeVitD supplementationMental health disordersHormone treatmentCohort studyRetrospective cohort studyYears post-menarcheModified Rotterdam criteriaFisher's exact testTertiary children's hospitalWilcoxon rank sum testEffects of hormonal treatmentAssociated with polycystic ovary syndromeCharacteristics of polycystic ovary syndromeRank sum testGender-affirming treatmentVitD levelsPrevalence of mental health disordersOvarian volumeMental health co-morbiditiesTreatment modalitiesEndocrinology clinicExact testPost-menarcheAnxiety diagnoses
2020
The association between anti-Müllerian hormone and vitamin 25(OH)D serum levels and polycystic ovarian syndrome in adolescent females
Simpson S, Seifer DB, Shabanova V, Lynn AY, Howe C, Rowe E, Caprio S, Vash-Margita A. The association between anti-Müllerian hormone and vitamin 25(OH)D serum levels and polycystic ovarian syndrome in adolescent females. Reproductive Biology And Endocrinology 2020, 18: 118. PMID: 33218348, PMCID: PMC7679991, DOI: 10.1186/s12958-020-00676-y.Peer-Reviewed Original ResearchConceptsPolycystic ovarian syndromeRotterdam diagnostic criteriaNon-PCOS groupMedian AMHOvarian syndromePCOS groupDiagnostic criteriaAnti-Müllerian hormone levelsAdolescent femalesRetrospective chart reviewTraditional clinical markersAnti-Müllerian hormoneCross-sectional studyWilcoxon rank sum testSignificant unadjusted differencesRank sum testD deficiencyChart reviewClinical featuresEndocrinology clinicSerum levelsAdjusted analysisUnadjusted comparisonsInsurance typeSurrogate marker